Author

Marshall R. Sack

Observed names: M SACK, M Sack, M. R. Sack, M. Sack, Marshall R Sack, Marshall Sack, Sack M

Institution: Radiant Research (United States)

Observed institutions: Hennepin County Medical Center, Orlando Clinical Research Center, Austin Diagnostic Clinic, Radiant Research (United States)

OpenAlex ID: A5034922033

Hydroxychloroquine concentration–response relationships in patients with rheumatoid arthritis

2002 · Tino Munster, John P. Gibbs, et al. · Arthritis & Rheumatism · 258

Capsaicin cream 0.025% as Monotherapy for Osteoarthritis: A double-blind study

1994 · Roy D. Altman, Allan Aven, et al. · Seminars in Arthritis and Rheumatism · 115

Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: A six‐month, double‐blind, randomized, dose‐ranging study

2002 · Daniel E. Furst, Kenneth Saag, et al. · Arthritis & Rheumatism · 109

Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: A randomized, double-blind six-week trial with eighteen-week extension

1999 · Daniel E. Furst, Herbert Lindsley, et al. · Arthritis & Rheumatism · 107

Prognostic factors in polyarteritis.

1975 · M Sack, J T Cassidy, et al. · PubMed · 98

Single-Dose Pharmacokinetics and Safety of Pegylated Interferon-α2b in Patients with Chronic Renal Dysfunction

2002 · Samir K. Gupta, Amy L. Pittenger, et al. · The Journal of Clinical Pharmacology · 84

Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency

2003 · Martha C. Chapelsky, Kathleen Thompson‐Culkin, et al. · The Journal of Clinical Pharmacology · 78

Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients

2001 · Jules I. Schwartz, Nancy G. B. Agrawal, et al. · The Journal of Clinical Pharmacology · 45

Phase I/II trial of recombinant methionyl human tumor necrosis factor binding protein PEGylated dimer in patients with active refractory rheumatoid arthritis.

2000 · L W Moreland, D P McCabe, et al. · PubMed · 43

Pharmacokinetics and Safety of the Ketolide Telithromycin in Patients with Renal Impairment

2004 · Jun Shi, Guy Montay, et al. · The Journal of Clinical Pharmacology · 42

Pharmacokinetics of Etoricoxib in Patients with Renal Impairment

2003 · Nancy G. B. Agrawal, Catherine Z. Matthews, et al. · The Journal of Clinical Pharmacology · 39

Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee

1995 · Arthur Weaver, Bernard Rubin, et al. · Clinical Therapeutics · 27

Multiple-Dose Pharmacokinetics of Pentoxifylline and its Metabolites during Renal Insufficiency

1996 · Christopher M Paap, Karon S Simpson, et al. · Annals of Pharmacotherapy · 23

Microemulsion formulation of cyclosporin (Sandimmun Neoral®) vs Sandimmun®: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis

2000 · D. E. Yocum, S. Allard, et al. · Rheumatology · 21

Effect of renal impairment on the pharmacokinetics of rosiglitazone (RSG)

1999 · M CHAPELSKY, K THOMPSON, et al. · Clinical Pharmacology & Therapeutics · 10

Pharmacokinetics and Safety of Telithromycin After Single and Multiple Doses in Patients with Renal Impairment

2003 · J. Shi, G. Montay, et al. · Clinical Pharmacology & Therapeutics

Single dose pharmacokinetics (PK) of peg-interferon alfa-2B (P) in subjects with various degrees of chronic renal insufficiency

2001 · Thomas Marbury, Kirstin Lambrecht, et al. · Clinical Pharmacology & Therapeutics

Abstracts of papers clinical pharmacological meeting

1993 · M. M. Klauw, B. H. Ch. Stricker, et al. · Pharmacy World & Science

Works count: 19

Citation count: 1,099

H-index: 14

I10-index: 15